Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2015, Article ID 608279, 6 pages
http://dx.doi.org/10.1155/2015/608279
Clinical Study

Mesenchymal Chondrosarcoma in Children and Young Adults: A Single Institution Retrospective Review

1Department of Oncology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
2Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN 38105, USA
3Department of Otolaryngology, University of Tennessee Health Science Center, Memphis, TN 38105, USA
4Department of Pathology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
5Department of Radiological Sciences, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
6Department of Radiology, University of Tennessee Health Science Center, Memphis, TN 38105, USA
7Department of Surgery, University of Tennessee Health Science Center, Memphis, TN 38105, USA
8Department of Biostatistics, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
9Department of Neurosurgery, University of Tennessee Health Science Center, Memphis, TN 38105, USA

Received 29 January 2015; Revised 4 May 2015; Accepted 21 May 2015

Academic Editor: Silvia Stacchiotti

Copyright © 2015 Michael W. Bishop et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. G. Huvos, G. Rosen, M. Dabska, and R. C. Marcove, “Mesenchymal chondrosarcoma. A clinicopathologic analysis of 35 patients with emphasis on treatment,” Cancer, vol. 51, no. 7, pp. 1230–1237, 1983. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Nakashima, K. K. Unni, T. C. Shives, R. G. Swee, and D. C. Dahlin, “Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases,” Cancer, vol. 57, no. 12, pp. 2444–2453, 1986. View at Publisher · View at Google Scholar · View at Scopus
  3. A. H. Salvador, J. W. Beabout, and D. C. Dahlin, “Mesenchymal chondrosarcoma—observations on 30 new cases,” Cancer, vol. 28, no. 3, pp. 605–615, 1971. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Bertoni, P. Picci, P. Bacchini et al., “Mesenchymal chondrosarcoma of bone and soft tissues,” Cancer, vol. 52, no. 3, pp. 533–541, 1983. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. Shakked, D. S. Geller, R. Gorlick, and H. D. Dorfman, “Mesenchymal chondrosarcoma: clinicopathologic study of 20 cases,” Archives of Pathology & Laboratory Medicine, vol. 136, no. 1, pp. 61–75, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. G. Guccion, R. L. Font, F. M. Enzinger, and L. E. Zimmerman, “Extraskeletal mesenchymal chondrosarcoma,” Archives of Pathology and Laboratory Medicine, vol. 95, no. 5, pp. 336–340, 1973. View at Google Scholar · View at Scopus
  7. M. Dabska and A. G. Huvos, “Mesenchymal chondrosarcoma in the young,” Virchows Archiv A: Pathological Anatomy and Histology, vol. 399, no. 1, pp. 89–104, 1983. View at Google Scholar
  8. E. J. Rushing, R. A. Armonda, Q. Ansari, and H. Mena, “Mesenchymal chondrosarcoma: a clinicopathologic and flow cytometric study of 13 cases presenting in the central nervous system,” Cancer, vol. 77, no. 9, pp. 1884–1891, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. P. D. Knott, F. H. Gannon, and L. D. R. Thompson, “Mesenchymal chondrosarcoma of the sinonasal tract: a clinicopathological study of 13 cases with a review of the literature,” The Laryngoscope, vol. 113, no. 5, pp. 783–790, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. E. F. Vencio, C. M. Reeve, K. K. Unni, and A. G. Nascimento, “Mesenchymal chondrosarcoma of the jaw bones: clinicopathologic study of 19 cases,” Cancer, vol. 82, no. 12, pp. 2350–2355, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. E. A. Eisenhauer, P. Therasse, J. Bogaerts et al., “New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1),” European Journal of Cancer, vol. 45, no. 2, pp. 228–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Therasse, S. G. Arbuck, E. A. Eisenhauer et al., “New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada,” Journal of the National Cancer Institute, vol. 92, no. 3, pp. 205–216, 2000. View at Google Scholar
  13. E. L. Kaplan and P. Meier, “Nonparametric estimation from incomplete observations,” Journal of the American Statistical Association, vol. 53, no. 282, pp. 457–481, 1958. View at Publisher · View at Google Scholar · View at MathSciNet
  14. S. Spunt, L. Million, J. R. Anderson et al., “Risk-based treatment for nonrhabdomyosarcoma soft tissue sarcomas (NRSTS) in patients under 30 years of age: Children's Oncology Group study ARST0332,” Journal of Clinical Oncology, vol. 32, supplement, abstr 10008, no. 5s, 2014. View at Google Scholar
  15. T. M. Dantonello, C. Int-Veen, I. Leuschner et al., “Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups,” Cancer, vol. 112, no. 11, pp. 2424–2431, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. G. D. Demetri and A. D. Elias, “Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas: implications for decision making in the clinic,” Hematology/Oncology Clinics of North America, vol. 9, no. 4, pp. 765–785, 1995. View at Google Scholar · View at Scopus
  17. M. Cesari, F. Bertoni, P. Bacchini, M. Mercuri, E. Palmerini, and S. Ferrari, “Mesenchymal chondrosarcoma. An analysis of patients treated at a single institution,” Tumori, vol. 93, no. 5, pp. 423–427, 2007. View at Google Scholar · View at Scopus
  18. A. Italiano, O. Mir, A. Cioffi et al., “Advanced chondrosarcomas: role of chemotherapy and survival,” Annals of Oncology, vol. 24, no. 11, pp. 2916–2922, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Kawaguchi, I. Weiss, P. P. Lin, W. W. Huh, and V. O. Lewis, “Radiation therapy is associated with fewer recurrences in mesenchymal chondrosarcoma,” Clinical Orthopaedics and Related Research, vol. 472, no. 3, pp. 856–864, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. S. L. Spunt, D. A. Hill, A. M. Motosue et al., “Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma,” Journal of Clinical Oncology, vol. 20, no. 15, pp. 3225–3235, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Ferrari, R. Miceli, A. Rey et al., “Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: results of a pooled analysis from United States and European groups,” European Journal of Cancer, vol. 47, no. 5, pp. 724–731, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Wang, T. Motoi, R. Khanin et al., “Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data,” Genes Chromosomes & Cancer, vol. 51, no. 2, pp. 127–139, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Nakayama, Y. Miura, J. Ogino et al., “Detection of HEY1-NCOA2 fusion by fluorescence in-situ hybridization in formalin-fixed paraffin-embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcoma,” Pathology International, vol. 62, no. 12, pp. 823–826, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Iso, L. Kedes, and Y. Hamamori, “HES and HERP families: multiple effectors of the Notch signaling pathway,” Journal of Cellular Physiology, vol. 194, no. 3, pp. 237–255, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. B. C. Belyea, S. Naini, R. C. Bentley, and C. M. Linardic, “Inhibition of the notch-hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis,” Clinical Cancer Research, vol. 17, no. 23, pp. 7324–7336, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. B. S. Taylor, N. Schultz, H. Hieronymus et al., “Integrative genomic profiling of human prostate cancer,” Cancer Cell, vol. 18, no. 1, pp. 11–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Strehl, K. Nebral, M. König et al., “ETV6-NCOA2: a novel fusion gene in acute leukemia associated with coexpression of T-lymphoid and myeloid markers and frequent NOTCH1 mutations,” Clinical Cancer Research, vol. 14, no. 4, pp. 977–983, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Sumegi, R. Streblow, R. W. Frayer et al., “Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family,” Genes Chromosomes & Cancer, vol. 49, no. 3, pp. 224–236, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. J. M. Mosquera, A. Sboner, L. Zhang et al., “Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma,” Genes Chromosomes & Cancer, vol. 52, no. 6, pp. 538–550, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. K. M. Nemeth, S. Federico, A. M. Carcaboso et al., “Subconjunctival carboplatin and systemic topotecan treatment in preclinical models of retinoblastoma,” Cancer, vol. 117, no. 2, pp. 421–434, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. K. McHugh and S. Kao, “Can paediatric radiologists resist RECIST (response evaluation criteria in solid tumours)?” Pediatric Radiology, vol. 33, no. 11, pp. 739–743, 2003. View at Publisher · View at Google Scholar · View at Scopus